B
099430
vs
K
KOSPI 200
Over the past 12 months, BioPlus Co Ltd has underperformed KOSPI 200, delivering a return of -20% compared to the KOSPI 200's +115% growth.
Stocks Performance
099430 vs KOSPI 200
Performance Gap
099430 vs KOSPI 200
Performance By Year
099430 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
BioPlus Co Ltd
Glance View
BioPlus Co., Ltd. is engaged in the manufacturing and supplying of diverse dermal fillers. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2021-09-27. The firm is engaged in the production and sale of biomaterials for tissue restoration used for temporary improvement of facial wrinkles, namely hyaluronic acid fillers. In addition, the Company is engaged in the production and sale of anti-adhesion agents that reduce the formation of adhesions in surgical areas, biomaterials for joint tissue repair, and other products.